Skip to main content
. 2019 Oct 12;34(1):13–23. doi: 10.1007/s12149-019-01408-y

Table 3.

Positive ratio of CDH17 and HER2 in gastric cancer specimens

Disease CDH17 HER2
Primary
 Grade 2 63.6% (7/11) 27.3% (3/11)
 Grade 3 56.5% (13/23) 8.70% (2/23)
LN
 Grade 2 85.7% (6/7) 28.6% (2/7)
 Grade 3 51.9% (14/27) 7.41% (2/27)

Primary primary gastric cancer, LN lymph node metastasis